# A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL

> **NCT07170254** · NA · RECRUITING · sponsor: **Shanghai BDgene Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- High-grade Squamous Intraepithelial Lesions (HSIL)

## Interventions

- **GENETIC:** BD114VLP, or BD114
- **GENETIC:** BD114VLP or BD114 plus Gel

## Key facts

- **NCT ID:** NCT07170254
- **Lead sponsor:** Shanghai BDgene Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07170254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07170254, "A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07170254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*